TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX): new label to be a 'preview of soon-to-be-published data'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $190.00 price target on TransMedics Group (NASDAQ: TMDX)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
